Fig. 6From: Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancerImmune-related histologic phenotype assessment criteria (irHPC). A Tumour-infiltrating lymphocytes (TILs). B Eosinophils. C Neutrophils. D Macrophages. E Irregular interface. F Dense plasma cells and neovascularization. G Lymphoid aggregate and proliferative (new) fibrosis. H TLSs. I Mature fibrosisBack to article page